Who reports and when, for the weeks ahead. The schedule comes from an outside feed; every figure beside it — the grade, the size, the multiple — is computed from the company's own SEC filings.
1,232 companies scheduled this month, 1216 of them covered here.
| Company | Grade | Size | P/E | Figures |
|---|---|---|---|---|
| UBS | Not rated | $163B | 20.67 | — |
| GSK | A | $106.5B | 13.41 | — |
| APH | A | $104B | 21.15 | — |
| ADP | A | $104B | 23.93 | — |
| PSX | B | $100.6B | 14.40 | — |
| BSX | B | $63.6B | 17.77 | — |
C | $62.2B | 39.81 | — | |
A | $55.9B | 32.37 | — | |
B | $33.5B | 24.42 | — | |
B | $18.8B | 10.05 | — | |
B | $17.7B | — | — | |
A | $17B | 33.10 | — | |
A | $14.3B | 14.91 | — | |
B | $13.8B | 16.97 | — | |
B | $8.4B | 18.15 | — | |
A | $7B | 20.26 | — | |
A | $3B | 25.73 | — | |
B | $2.5B | 23.03 | — | |
A | $517.4M | 33.47 | — | |
B | $355M | — | — |
| Company | Grade | Size | P/E | Figures |
|---|---|---|---|---|
A | $174.8B | 17.03 | — | |
| Not rated | $163.5B | 14.30 | — | |
A | $93B | 15.90 | — | |
B | $76.1B | 28.57 | — | |
| Not rated | $49.3B | — | — | |
A | $40.4B |
| Company | Grade | Size | P/E | Figures |
|---|---|---|---|---|
C | $1.39T | 326.80 | — | |
B | $405.4B | 56.24 | — | |
A | $256.4B | 27.64 | — | |
A | $95.6B | 56.18 | — | |
B | $84.9B | 43.64 | — | |
| 29.27 |
| — |
A | $30.7B | 13.93 | — |
B | $16B | 5.98 | — |
B | $9.3B | 15.49 | — |
A | $7.9B | 19.46 | — |
A | $7.6B | 10.40 | — |
A | $7B | 17.70 | — |
A | $5.3B | — | — |
D | $4.4B | 18.33 | — |
| Not rated | $4.2B | 13.31 | — |
| $78.8B |
| 28.85 |
| — |
A | $72.8B | 47.43 | — |
B | $69.6B | 27.31 | — |
B | $67.8B | 19.52 | — |
C | $63.5B | 25.88 | — |
A | $49.2B | 39.09 | — |
D | $28.5B | 34.05 | — |
A | $28.1B | 29.26 | — |
D | $25.2B | 23.85 | — |
A | $24.8B | 14.91 | — |
B | $20.6B | 26.29 | — |
F | $16.6B | 16.20 | — |
B | $15.3B | 4.99 | — |
A | $13.4B | 25.17 | — |
A | $13B | 327.60 | — |
A | $12.9B | 18.71 | — |
C | $12.8B | 11.02 | — |
B | $12.6B | 24.64 | — |
A | $12.5B | 16.00 | — |
A | $12.4B | 18.22 | — |
A | $11.4B | 29.36 | — |
A | $11.3B | 10.00 | — |
A | $10.4B | 305.79 | — |
A | $9.7B | 10.53 | — |
D | $7.2B | 9.48 | — |
C | $7.1B | 39.20 | — |
D | $6.9B | 9.95 | — |
A | $6.4B | — | — |
F | $5.6B | — | — |
B | $5B | 10.50 | — |
B | $4.6B | 40.20 | — |
B | $4.1B | 12.14 | — |
A | $4.1B | 11.01 | — |
D | $4B | — | — |
B | $3.9B | 17.30 | — |
D | $3.9B | 15.03 | — |
F | $3.8B | 32.07 | — |
F | $3.7B | — | — |
A | $3.6B | 10.87 | — |
| Not rated | $2.8B | — | — |
F | $2.7B | — | — |
B | $2.7B | 30.85 | — |
A | $2.6B | 19.36 | — |
D | $2.5B | 11.82 | — |
A | $2.5B | 11.22 | — |
C | $2.4B | 10.14 | — |
| Not rated | $2B | 3.50 | — |
A | $2B | 15.31 | — |
A | $1.7B | 12.44 | — |
B | $1.7B | 8.99 | — |
D | $1.7B | 13.28 | — |
B | $1.7B | 12.90 | — |
B | $1.6B | 16.53 | — |
A | $1.6B | 11.71 | — |
D | $1.6B | 19.62 | — |
B | $1.6B | 42.28 | — |
A | $1.4B | 12.22 | — |
F | $1.4B | 16.97 | — |
A | $1.3B | 12.29 | — |
A | $1.3B | 14.01 | — |
B | $1.3B | 8.72 | — |
A | $1.1B | 28.59 | — |
A | $1.1B | 11.92 | — |
C | $1B | 801.59 | — |
B | $976.1M | 14.65 | — |
F | $968.6M | — | — |
B | $905.6M | 12.54 | — |
B | $900.6M | 10.34 | — |
D | $875.2M | 194.06 | — |
F | $852.3M | — | — |
A | $780.3M | 11.00 | — |
A | $763.7M | 12.01 | — |
A | $709.7M | 10.63 | — |
A | $540.4M | 7.99 | — |
B | $538M | 29.90 | — |
F | $490.7M | — | — |
D | $445.3M | 18.66 | — |
C | $431.4M | 46.20 | — |
A | $391.9M | 8.68 | — |
A | $380.9M | 10.02 | — |
D | $346.2M | 38.60 | — |
D | $321.9M | 22.50 | — |
A | $320.5M | 10.53 | — |
C | $285.4M | 12.03 | — |
D | $271.2M | — | — |
A | $267.4M | 10.84 | — |
D | $227.9M | — | — |
B | $178.9M | 14.84 | — |
A | $144.5M | 16.14 | — |
D | $3.9M | — | — |
| FRBAnot covered | Not rated | — | — | — |
| TOWNnot covered | Not rated | — | — | — |
B | — | — | — |